- Research & Development
- About us
- Invest in us
- Malaria & medicines
Access & Product Management Advisory Committee (APMAC)
The function of the Access & Product Management Advisory Committee (APMAC) is to advise MMV's Access team on appropriate strategies to achieve its goals.
The APMAC is composed of 10 to 20 members, nominated by the President and CEO. Members are appointed for 2 to 4 years, with appointments staggered so as to provide a rotating membership.
The members of the APMAC come from both industry and academia and cover the full range of expertise required to achieve access objectives.
Prof Christian Lengeler, Head, Health Interventions Unit, Swiss Tropical and Public Health Institute, Switzerland; and Chairman of MMV APMAC
Dr Neena Valecha, Director, National Institute of Malaria Research (NIMR), Indian Council of Medical Research (ICMR), India; and Vice Chairman of MMV APMAC
Ms Valentina Buj, Health Specialist (Malaria Partnerships), UNICEF, NY, USA
Dr Elizabeth Chizema, Head of Research, Ministry of Health, Zambia
Dr Graciela Diap, Associate Staff of DNDi and FACT Medical Coordinator, Spain
Dr Alexander Dodoo, Head, Centre for Tropical Clinical Pharmacology & Therapeutics (CTCPT), Ghana
Dr Gunther Faber, Chairman, One Family Health, UK
Dr Douglas Lungu, Hospital Director, Daeyang Luke Hospital, Malawi
Dr David McGibney, Pharmaceutical Research and Development Expert; Consultant Pharmaceutical Physician; and Co-Chairman MMV ESAC (Development)
Prof Ric Price, Associate Professor at Menzies School of Health Research, Darwin, Australia
Dr Melanie Renshaw, Chief technical advisor, African Leaders Malaria Alliance’s (ALMA), Kenya
Dr Claude Emile Rwagacondo, Coordinator of West Africa Roll Back Malaria Network (WARN), Senegal
Dr Richard W. Steketee, MD, MPH, Science Director, Malaria Control Program and MACEPA, PATH, USA
Dr G.S Sonal, Additional Director and Head of Malaria Division of the National Vector Borne Disease Control Programme (NVBDCP), India
Prof Andy Stergachis, Professor of Epidemiology and Global Health, Adjunct Professor of Pharmacy and Health Services, Director of the Global Medicines Program, University of Washington
Dr Brenda Waning, Coordinator of Market Dynamics at UNITAID, Switzerland